Metabolic syndrome: screening, diagnosis, and management
Elissa Lane Miller1, Angela Mitchell
1elissa.miller@midwives.org
Journal of Midwifery & Women'S Health
|May 2, 2006
Summary
Metabolic syndrome is a serious health issue affecting women, increasing cardiovascular risk. This review covers its unique risk factors, screening, and management in women.
Area of Science:
- Women's Health
- Cardiovascular Health
- Endocrinology
Background:
- Metabolic syndrome is a cluster of conditions that significantly elevates the risk of cardiovascular disease.
- Its prevalence is notably higher in women, often co-occurring with gynecological and pregnancy-related conditions.
- These associated conditions include polycystic ovary syndrome, gestational diabetes, pregnancy-induced hypertension, and female sexual dysfunction.
Purpose of the Study:
- To provide a comprehensive overview of metabolic syndrome specifically within the context of women's health.
- To highlight the unique risk factors and clinical presentations in the female population.
- To discuss current screening strategies and therapeutic management approaches.
Main Methods:
- This study is a review of existing literature on metabolic syndrome in women.
- It synthesizes information regarding prevalence, associated conditions, risk factors, screening, and treatment.
- The focus is on evidence-based practices and clinical considerations relevant to female patients.
Main Results:
- Metabolic syndrome presents distinct challenges and higher prevalence in women.
- Specific conditions like PCOS and gestational diabetes are closely linked to metabolic syndrome in women.
- Effective screening and tailored management are crucial for mitigating cardiovascular risk.
Conclusions:
- Metabolic syndrome poses a significant and growing threat to women's cardiovascular health.
- Understanding its unique associations and risk factors in women is essential for early detection and intervention.
- Comprehensive management strategies are vital to improve outcomes and reduce long-term cardiovascular events.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...